Finance

Lists
BLS:ASX
BLS Pharmaceuticals Ltd
A$1.14
+2.70%
(+0.030) 1D
Sep 4, 4:10:25 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BLS...
Open
A$1.10
High
A$1.17
Low
A$1.10
Mkt. cap
261.36M
Avg. vol.
255.89K
Volume
445.23K
P/E ratio
29.07
52-wk high
A$1.20
52-wk low
A$0.76
EPS
A$0.04
Shares outstanding
230.30M
No. of employees
16
Open
A$1.10
High
A$1.17
Low
A$1.10
Mkt. cap
261.36M
Avg. vol.
255.89K
Volume
445.23K
P/E ratio
29.07
52-wk high
A$1.20
52-wk low
A$0.76
EPS
A$0.04
Shares outstanding
230.30M
No. of employees
16
News stories
From web sources and news partners
About BLS Pharmaceuticals Ltd
CEO-
Employees16
Founded1998
Headquarters-
SectorHealth care
Websiteblspharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
8.36M
8.36M
15.58M
15.58M
Cost of goods sold
5.87M
5.87M
6.86M
6.86M
Cost of revenue
5.87M
5.87M
6.86M
6.86M
Research and development expenses
34.77K
34.77K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.16M
1.16M
3.16M
3.16M
Operating expense
1.73M
1.73M
3.78M
3.78M
Total operating expenses
7.61M
7.61M
10.63M
10.63M
Operating income
750.68K
750.68K
4.94M
4.94M
Other non operating income
-33.21K
-33.21K
-1.09M
-1.09M
EBT including unusual items
800.54K
800.54K
3.67M
3.67M
EBT excluding unusual items
800.54K
800.54K
3.80M
3.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
811.86K
811.86K
3.67M
3.67M
Net profit margin
9.71%
9.71%
23.57%
23.57%
Earnings per share
-
-
-
-
Interest and investment income
38.77K
38.77K
-
-
Interest expense
-
-
-48.48K
-48.48K
Net interest expenses
38.77K
38.77K
-48.48K
-48.48K
Depreciation and amortization charges
42.13K
42.13K
311.69K
311.69K
EBITDA
864.04K
826.43K
5.12M
5.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps